NPLB Response: Senate Finance RFI on Drug Pricing
In June 2026, Senate Finance Committee Democrats issued a Request for Information seeking stakeholder input on proposals to lower prescription drug costs for American patients. As a coalition of patients, researchers, investors, and physicians committed to a future of affordable innovation, No Patient Left Behind submitted the following response.
View our full response here.
+ Find the original Senate RFI language here.
We’re building support across the biotech ecosystem
BECOME A FIRST RESPONDER & THOUGHT PARTNER
Sign up to receive action alerts. Help protect access to lifesaving medicines & preserve innovation for those still waiting for a cure.